| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
177,680,000 |
| Market
Cap: |
7.94(B) |
| Last
Volume: |
1,420,394 |
Avg
Vol: |
1,949,015 |
| 52
Week Range: |
$44.82 - $99.04 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
| |
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 568 |
| Guru Rank Value : 3 |
| Guru Occurances : 1 |
|
|
|
|
|
| |
|
Company Profile Exact Sciences is a cancer screening and diagnostics company. Co.'s primary screening product, the Cologuard® test, is a non-invasive stool-based DNA screening test that utilizes a multi-target approach to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. Co.'s portfolio of Oncotype tests include: Oncotype DX gene expression tests for breast, prostate and colon cancers; Oncotype DX AR-V7 Nucleus Detect® test, a liquid-based test for advanced stage prostate cancer; and Oncotype MAP™ Pan-Cancer Tissue test (oncomap test), a test delivering tumor profiling to aid therapy selection for patients with metastatic, refractory or recurrent cancer.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
6,762 |
108,398 |
166,494 |
290,334 |
| Total Sell Value |
$463,948 |
$6,570,910 |
$11,277,891 |
$18,676,003 |
| Total People Sold |
8 |
10 |
11 |
11 |
| Total Sell Transactions |
11 |
52 |
61 |
100 |
| End Date |
2024-03-07 |
2023-12-05 |
2023-06-06 |
2022-06-06 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Conroy Kevin T |
President and CEO |
• • – |
2021-02-23 |
4 |
OE |
$0.00 |
$0 |
D/D |
34,325 |
826,785 |
|
- |
|
| Condella Sarah |
SVP, Human Resources |
• – – |
2021-02-23 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,300 |
73,004 |
|
- |
|
| Lidgard Graham Peter |
Chief Science Officer |
• – – |
2021-02-23 |
4 |
OE |
$0.00 |
$0 |
D/D |
11,575 |
47,171 |
|
- |
|
| Orville Jacob A |
General Manager, New Ventures |
• – – |
2021-02-19 |
4 |
AS |
$143.38 |
$243,172 |
D/D |
(1,696) |
5,445 |
|
-16% |
|
| Coward D Scott |
Chief Administrative Officer |
• – – |
2021-02-18 |
4 |
AS |
$140.79 |
$278,764 |
D/D |
(1,980) |
1,301 |
|
-10% |
|
| Orville Jacob A |
General Manager, New Ventures |
• – – |
2021-02-18 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,649 |
7,141 |
|
- |
|
| Conroy Kevin T |
President and CEO |
• • – |
2021-02-17 |
4 |
AS |
$142.66 |
$2,257,595 |
D/D |
(15,825) |
792,460 |
|
-7% |
|
| Orville Jacob A |
General Manager, New Ventures |
• – – |
2021-02-17 |
4 |
AS |
$142.66 |
$147,368 |
D/D |
(1,033) |
3,492 |
|
-7% |
|
| Lidgard Graham Peter |
Chief Science Officer |
• – – |
2021-02-17 |
4 |
AS |
$142.66 |
$304,008 |
D/D |
(2,131) |
35,596 |
|
-7% |
|
| Elliott Jeffrey Thomas |
Chief Financial Officer |
• – – |
2021-02-17 |
4 |
AS |
$142.66 |
$288,173 |
D/D |
(2,020) |
40,313 |
|
-7% |
|
| Coward D Scott |
Chief Administrative Officer |
• – – |
2021-02-17 |
4 |
AS |
$142.66 |
$284,179 |
D/D |
(1,992) |
3,281 |
|
-7% |
|
| Condella Sarah |
SVP, Human Resources |
• – – |
2021-02-17 |
4 |
AS |
$142.66 |
$147,368 |
D/D |
(1,033) |
68,704 |
|
-7% |
|
| Conroy Kevin T |
President and CEO |
• • – |
2021-02-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
31,132 |
808,285 |
|
- |
|
| Orville Jacob A |
General Manager, New Ventures |
• – – |
2021-02-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,030 |
4,525 |
|
- |
|
| Lidgard Graham Peter |
Chief Science Officer |
• – – |
2021-02-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,972 |
37,727 |
|
- |
|
| Elliott Jeffrey Thomas |
Chief Financial Officer |
• – – |
2021-02-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,972 |
42,333 |
|
- |
|
| Coward D Scott |
Chief Administrative Officer |
• – – |
2021-02-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,972 |
5,273 |
|
- |
|
| Condella Sarah |
SVP, Human Resources |
• – – |
2021-02-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,030 |
69,737 |
|
- |
|
| Conroy Kevin T |
President and CEO |
• • – |
2021-02-05 |
4 |
OE |
$5.70 |
$99,995 |
D/D |
17,543 |
777,153 |
|
- |
|
| Conroy Kevin T |
President and CEO |
• • – |
2021-02-01 |
4 |
AS |
$138.07 |
$4,189,596 |
D/D |
(30,344) |
759,610 |
|
-12% |
|
| Conroy Kevin T |
President and CEO |
• • – |
2021-01-04 |
4 |
AS |
$128.74 |
$4,095,734 |
D/D |
(31,814) |
825,704 |
|
-27% |
|
| Coward D Scott |
Chief Administrative OfficerOf |
• – – |
2020-12-30 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
4,073 |
|
-28% |
|
| Coward D Scott |
Chief Administrative OfficerOf |
• – – |
2020-12-30 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
1,301 |
|
-28% |
|
| Lidgard Graham Peter |
Chief Science OfficerOfficer |
• – – |
2020-12-30 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
17,398 |
|
-28% |
|
| Lidgard Graham Peter |
Chief Science OfficerOfficer |
• – – |
2020-12-30 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
33,755 |
|
-28% |
|
957 Records found
|
|
Page 14 of 39 |
|
|
0.88 (1.93%) 
